Pyrogen Testing Market Overview 2024-2033: Comprehensive Analysis of Size, Share, Trends, and Outlook

The pyrogen testing market size has grown rapidly in recent years. It will grow from $1.46 billion in 2023 to $1.67 billion in 2024 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to pharmaceutical and biotechnology industry growth, regulatory requirements for drug safety, advancements in testing methods, increase in infectious disease outbreaks, adoption in medical device manufacturing..

The pyrogen testing market size is expected to see rapid growth in the next few years. It will grow to $2.72 billion in 2028 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to customized pyrogen testing solutions, expansion of rapid and automated testing, innovation in in vitro pyrogen detection, adoption of pyrogen testing in cell therapy, environmental and sustainable testing practices.. Major trends in the forecast period include point-of-care pyrogen testing, regulatory compliance in pyrogen testing, ai-driven pyrogen detection and analysis, personalized and patient-specific pyrogen testing, transparency and traceability in testing processes..

Market Overview -
The pyrogen testing provide pyrogen testing to check the presence or absence of pyrogens in all aqueous parenteral. Pyrogen testing determines the presence of bacterial toxins in vaccines, biotechnological products, and drugs, which induces fever in humans. It also determines the presence of microbes and their metabolites in drugs during the manufacturing process.

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=4020&type=smp

Rising Investments In R&D By Pharmaceutical Companies Boost Pyrogen Testing Market
The rising investments in research and development in the pharmaceutical and biotechnology industries contributed to the growth of the pyrogen testing market. Pyrogen testing is used by pharmaceutical, biotech, and various drug manufacturing companies for the safe manufacturing and introduction of infection-free products into the market. For instance, in 2021, major players in the pharmaceuticals market Roche, AstraZeneca and Merck have invested heavily in R&D activities. Roche invested around $13.5 billion (13.7 bn CHF) which was up by 14.3% from 2020. Therefore, high investments in research and development by pharmaceutical companies drive the pyrogen testing market.

Competitive Landscape -
Major companies operating in the pyrogen testing market include Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories Inc., Lonza Group Ltd., Ellab A/S, Nelson Laboratories LLC, Associates of Cape Cod Inc., GenScript Biotech Corporation, bioMérieux SA, Hyglos GmbH, Sanquin Blood Supply Foundation, Wako Chemicals USA Inc., Pyrostar International Inc., Eurofins Scientific SE, SGS SA, WuXi AppTec Group, Sigma-Aldrich Co. LLC, Bio-Rad Laboratories Inc., Microcoat Biotechnologie GmbH, Sartorius AG, Pacific Biolabs Inc., Toxikon Corporation, STERIS Corporation, Avance Biosciences Inc., BioReliance Corporation, Microbiological Consulting LLC, Microbac Laboratories Inc., North American Science Associates Inc., Pace Analytical Life Sciences LLC

Animal-Free Pyrogen Testing With Pyrodetect And Pyromat Mat Systems
Companies are focusing on the evolution of various animal-free pyrogen testing methods such as monocyte activation assay (MAT) to overcome constraints of rabbit pyrogen testing method and LAL test and to produce a human treatment of animals. MAT provides a high level of prediction of pyrogenic activity and also stimulates fever reaction better than the RPT or BET/LAL. MAT pyrogen testing method is used to detect both endotoxin and non-endotoxin pyrogens, but the LAL test is limited to detecting only endotoxin pyrogen. For instance, Merck focused on two MAT systems for the detection of pyrogens, namely PyroDetect, PyroMAT.

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/pyrogen-testing-global-market-report

Key Segments -

The pyrogen testing market covered in this report is segmented -
1) By Test Type: LAL Test, In Vitro Test, Rabbit Test
2) By Product And Service: Assays, Kits, And Reagents, Instruments, Services
3) By Application: Pharmaceutical And Biologics, Medical Devices, Other Applications

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

"Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

"Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps"

This release was published on openPR.